Affiliation:
1. Federal State Budgetary Institution «National Research Center for Epidemiology and Microbiology named after honorary academician N.F. Gamalei» of the Ministry of Health of the Russian Federation
Abstract
Aim. To identify the frequency of occurrence of staphylococcal enterotoxins of the SEC and SEI type produced by Staphylococcus aureus strains isolated from patients with different nosology. As you know, the infection process in them proceeds with severe intoxication without vomiting and intestinal disorders.Materials and methods. 79 strains were studied (43 were isolated in case of pneumonia, 13 - in burns, 11 - in sepsis) S. aureus in the presence of SES and SEI using enzymelinked immunosorbent assay (ELISA).Results. It was found that 48.3% of S. aureus strains isolated from patients with pneumonia produced SEC and 72.1% - SEI. The frequency of occurrence of S. aureus strains producing SEC and SEI isolated in patients with burn infections was 23.0 and 15.4%, respectively. 36.4% of staphylococcal strains isolated in patients with sepsis produced SEC, 45.5% - SEI.Discussion. It was found that the proportion of S. aureus cultures producing SEC enterotoxins during sepsis is significantly higher than the strains producing SEB (5.4%) and much smaller than SEA (75.6%). A high percentage of SEI-positive strains was found compared to strains that produce the classic enterotoxins SEA, SEB and SEC isolated from pneumonia. In burn infections, the proportions of strains producing SEC and SEI were 15.4 and 23.0%, respectively, which is significantly lower than SEA (92.9%).Conclusion. The data obtained indicate the need to identify staphylococcus strains that produce both classic and newly discovered enterotoxins, which are crucial virulence factors leading to lethal sepsis, infectious endocarditis and toxic shock syndrome to eliminate them.
Publisher
Central Research Institute for Epidemiology
Reference26 articles.
1. Reddy P.N., Srirama K., Dirisala V.R. An update on clinical burden, diagnostic tools, and therapeutic options of Staphylococcus aureus. Infect. Dis. (Auckl). 2017; 10: 1179916117703999. Doi: https://doi.org/10.1177/1179916117703999
2. Fowler V.G. Jr., Olsen M.K., Corey G.R., Woods C.W., Cabell C.H., Reller L.B., et al. Clinical identifiers of complicated Staphylococcus aureus bacteremia. Arch. Intern. Med. 2003; 163(17): 2066-72. Doi: https://doi.org/10.1001/archinte.163.17.2066
3. Tibekin A.T., Salodovnikov Yu.P., Filatov N.N., Kobzeeva O.B., Ermolenko M.V., Artamonova L.I., et al. A rare epidemiological outbreak of acute intestinal infections in adults. Zhurnal mikrobiologii, epidemiologii i immunobiologii. 1998, (6): 116-8. (in Russian)
4. Ryabichenko E.V., Shcheglovitova O.N., Bondarenko V.M., Ezepchuk Yu.V. Production of inflammatory mediators by mouse peritoneal cells under the combined effects of staphylococcal enterotoxin and lipopolysaccharide. Zhurnal mikrobiologii, epidemiologii i immunobiologii. 1999; (6): 21-4. (in Russian)
5. Tuffs S.W., Haeryfar S.M.M., McCormick J.K. Manipulation of Innate and Adaptive Immunity by Staphylococcal Superantigens. Pathogens. 2018; 7(2): 53. Doi: https://doi.org/10.3390/pathogens7020053